Sergey Terushkin, MD, FACS is a board-certified bariatric surgeon and medical weight loss specialist practicing in Florida
Semaglutide is recommended for people with obesity, BMI greater than 30 kg/m2 or BMI greater than 27 Kg/m2 with a weight-related condition like diabetes type II or high blood pressure or high cholesterol
Improved Metabolic Markers: Beyond weight loss, these treatments may positively influence blood sugar, cholesterol, and blood pressure levels
The FDA removed tirzepatide from its drug shortage list, which ended the temporary regulatory flexibility that had allowed compounding pharmacies to produce tirzepatide formulations
When Abrupt Discontinuation Is Acceptable Three scenarios justify stopping without a taper
While semaglutide is associated with NAION, the increased risk of NAION appears more closely linked to the underlying conditions rather than the medication itself. Other ways Ozempic or Wegovy may affect your vision While the link between semaglutide and NAION blindness isnt fully understood yet, its still important to monitor any vision changes while taking medications like Ozempic or Wegovy